BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.376,73 PKT -7,97 PKT -0,58 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
06.04.05 Roche Buy Helvea
06.04.05 Swiss Life Sell Merck Finck & Co
07.04.05 Swiss Life Neutral Sarasin Research
06.04.05 Swiss Life Accumulate Helvea
07.04.05 Swiss Life Overweight Lehman Brothers
06.04.05 Swiss Life Overweight JP Morgan
06.04.05 Zurich Insurance Outperform Goldman Sachs
05.04.05 Zurich Insurance Buy Sarasin Research
04.04.05 Givaudan Neutral Sarasin Research
04.04.05 Swiss Life Overweight JP Morgan
05.04.05 Adecco SA Sell Dresdner Kleinwort Wasserstein
05.04.05 Adecco SA Accumulate Helvea
04.04.05 Adecco SA Market Outperform Vontobel
04.04.05 Swiss Life Neutral Sarasin Research
01.04.05 Swisscom Neutral Helvea
31.03.05 Swiss Life Overweight Lehman Brothers
01.04.05 Swiss Life Outperform HypoVereinsbank
30.03.05 Swisscom Neutral Sarasin Research
29.03.05 Roche Buy Sarasin Research
24.03.05 Roche Sector Outperform Vontobel
24.03.05 Swisscom Neutral Sarasin Research
22.03.05 UBS Buy Merrill Lynch
22.03.05 ABB (Asea Brown Boveri) Overweight JP Morgan
22.03.05 Roche Buy Sarasin Research
23.03.05 UBS Neutral Merrill Lynch
21.03.05 Holcim Neutral Sarasin Research
22.03.05 Adecco SA Accumulate Helvea
22.03.05 Swisscom Neutral Helvea
21.03.05 ABB (Asea Brown Boveri) Neutral Sarasin Research
22.03.05 Holcim Accumulate Helvea
22.03.05 Geberit Reduce Helvea
22.03.05 ABB (Asea Brown Boveri) Accumulate Helvea
21.03.05 Novartis Neutral Sarasin Research
21.03.05 Novartis Kaufen Helaba Trust
22.03.05 Novartis Accumulate Helvea
18.03.05 Adecco SA Outperform Goldman Sachs
21.03.05 Geberit Market Outperform Vontobel
21.03.05 Novartis Neutral Sarasin Research
17.03.05 UBS Buy Helvea
18.03.05 ABB (Asea Brown Boveri) Overweight Lehman Brothers